Tear-Like Antioxidant Formulations for Accurate Ocular Irritation Tests
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nonanimal ocular irritation tests exhibit high false positive rates due to the failure to model the antioxidant properties of tears, which are crucial for preventing initial damage by inactivating reactive molecules, and lack the ability to accurately predict the reversibility of eye irritation.
Innovation Solution
Incorporating antioxidant formulations, such as those found in tears, into in vitro ocular irritancy test systems to interact with the test substance before or during exposure, allowing for the measurement of cell viability after exposure and reducing false positive rates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If nonanimal ocular irritation tests are used to replace animal testing, then ethical concerns are addressed and animal welfare is improved, but the tests exhibit high false positive rates due to failure to model tear antioxidant properties
Solution Approach 1:
The patent introduces tear film antioxidants (ascorbic acid, uric acid, alpha-tocopherol) as intermediary substances that mediate between the test substance and the corneal epithelium. These antioxidants replicate the protective function of natural tears by scavenging reactive oxygen species and other reactive molecules generated by test substances, thereby preventing false positive irritation responses and improving prediction accuracy.
Solution Approach 2:
The patent modifies the test system by adding specific concentrations of antioxidants (ascorbic acid 0.5-5.0 mM, uric acid 0.1-1.0 mM, alpha-tocopherol 1-10 μM) to change the chemical environment. This parameter change replicates the redox buffer capacity of natural tears, allowing the test system to accurately distinguish between substances that cause true irritation versus those that generate reactive molecules normally neutralized by tears.
2Reliability
If antioxidants are added to the test system, then false positive rates are reduced, but the complexity of the test procedure increases
Solution Approach 1:
The patent makes the test system universally applicable by incorporating antioxidants that replicate natural tear composition. This multi-functional approach allows the same test system to evaluate diverse test substances (chemicals, cosmetics, pharmaceuticals) while maintaining physiological relevance through the constant presence of tear-like antioxidants, simplifying the overall testing framework.
Solution Approach 2:
The antioxidants are pre-added to the test system before exposure to test substances, establishing a protective chemical environment in advance. This preliminary action ensures that reactive molecules are immediately scavenged upon generation, eliminating the need for complex post-exposure interventions or multiple test variants.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The addition of tear-like antioxidants significantly reduces false positive rates in nonanimal eye irritation tests without compromising sensitivity, providing a more accurate prediction of ocular irritancy.
Implementation Method 1
the antioxidant formulation under conditions in which antioxidant is allowed to interact with the test substance
Data Source
AI summary
The disclosure relates to formulations and methods for the in vitro testing of ocular irritants. It was discovered that adding an antioxidant formulation to in vitro ocular irritation tests, including for example, a biochemical ocular irritation test, a reconstituted human corneal epithelium (RhCE) ocular irritation test and an excised eye depth of injury (DoI) test, substantially reduces the rate of false positives without diminishing test sensitivity, resulting in more accurately predicting ocular irritancy of test substances. More particularly, the disclosed method employs relatively high physiologic concentrations of one or more antioxidants that are normally present in tears. In a variation, much higher concentrations of one or more antioxidants may provide protection against in vivo exposure to ocular irritants.